[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100587986":3},{"organization":4,"outcomesModule":7,"designInfo":18,"detailedDescription":24,"studyPopulation":17,"armGroups":25,"interventions":36,"overallOfficials":42,"centralContacts":46,"locations":55,"responsibleParty":75,"collaborators":17,"id":77,"slug":17,"hasResults":78,"nctId":79,"briefTitle":80,"officialTitle":80,"acronym":81,"eligibilityCriteria":82,"healthyVolunteers":78,"sex":83,"minAge":84,"maxAge":17,"enrollmentInfo":85,"targetDuration":17,"studyType":88,"phases":89,"briefSummary":91,"conditions":92,"keywords":17,"overallStatus":57,"whyStopped":17,"lastUpdateSubmitDate":100,"lastUpdatePostDateStruct":101,"startDateStruct":104,"completionDateStruct":106,"leadSponsor":108,"locationsCount":109},{"fullName":5,"class":6},"Affiliated Hospital of Nantong University","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":17},[9],{"measure":10,"description":11,"timeFrame":12},"medication adherence and risk factor control rates","1.The medication rates and control rates for hypertension; 2.The medication rates and control rates for hyperglycemia; 3. The medication rates and control rates for hyperlipidemia; 4.The medication rates and control rates for obesity.","6 months",[14],{"measure":15,"description":16,"timeFrame":12},"incident vascular events, including stroke, coronary heart disease (CHD), peripheral vascular disease (PVD), and other related cardiovascular events","Stroke is a sudden interruption of blood flow to the brain, caused by either a blockage (ischemic stroke) or rupture of a blood vessel (hemorrhagic stroke). Coronary heart disease is a cardiovascular condition characterized by the narrowing or blockage of the coronary arteries, the blood vessels that supply oxygen-rich blood to the heart muscle. Peripheral vascular diseases are circulatory disorders characterized by narrowing, blockage, or spasms in blood vessels outside the heart and brain, most commonly affecting arteries supplying the legs, arms, kidneys, or stomach.",null,{"allocation":19,"interventionModel":20,"interventionModelDescription":17,"primaryPurpose":21,"observationalModel":17,"timePerspective":17,"maskingInfo":22},"RANDOMIZED","PARALLEL","PREVENTION",{"masking":23,"maskingDescription":17,"whoMasked":17},"NONE","A randomized controlled study was conducted on the application of smart wearable devices in the intervention of high-risk populations for stroke, with a focus on whether the functions of smart wearable devices such as medication reminders, heart rate monitoring, and exercise reminders can effectively benefit the improvement of key risk factors for stroke, especially blood pressure, blood glucose, and blood lipids.",[26,32],{"label":27,"type":28,"description":29,"interventionNames":30},"With Wearable Devices","EXPERIMENTAL","Participants utilize wearable devices (smart wristbands) 24 hours a day for 6 months and receive medication reminders for each use and heart rate monitoring.",[31],"Behavioral: Wearable Devices",{"label":33,"type":34,"description":35,"interventionNames":17},"Without Wearable Devices","NO_INTERVENTION","Participants do not utilize wearable devices (smart wristbands) .",[37],{"type":38,"name":39,"description":40,"armGroupLabels":41,"otherNames":17},"BEHAVIORAL","Wearable Devices","Participants utilize wearable devices (smart wristbands) 24 hours a day for 6 months. Wearable devices can provide medication reminders for each use and heart rate monitoring.",[27],[43],{"name":44,"affiliation":5,"role":45},"Qiuhong Ji, MD, PhD","STUDY_CHAIR",[47,51],{"name":44,"role":48,"phone":49,"phoneExt":17,"email":50},"CONTACT","+8613962916293","jiqiuhong@ntu.edu.cn",{"name":52,"role":48,"phone":53,"phoneExt":17,"email":54},"Pengyu Gong, MD","+8615720800870","gongpengyu@ntu.edu.cn",[56],{"facility":5,"status":57,"city":58,"state":59,"zip":60,"country":61,"countryCode":62,"cosmosGeoPoint":63,"geoPoint":68,"contacts":69},"RECRUITING","Nantong","Jiangsu","226000","China","CN",{"type":64,"coordinates":65},"Point",[66,67],120.87472,32.03028,{"lat":67,"lon":66},[70,71],{"name":44,"role":48,"phone":49,"phoneExt":17,"email":50},{"name":72,"role":48,"phone":73,"phoneExt":17,"email":74},"Tian Xu, MD, PhD","+8618251313276","xutian84@163.com",{"type":76,"investigatorFullName":17,"investigatorTitle":17,"investigatorAffiliation":17,"oldNameTitle":17,"oldOrganization":17},"SPONSOR","100587986",false,"NCT06935513","Wearable Devices Empowering Active Health Initiatives for High-Risk Stroke Populations","AISP","Inclusion Criteria:\n\n1. Diagnosed with hypertension;\n2. Diagnosed with diabetes;\n3. Diagnosed with atrial fibrillation;\n4. Smoking subjects;\n5. Physical inactive subjects；\n6. Obesity and overweight subjects;\n7. Must be able to use smart wearable devices.\n\nExclusion Criteria:\n\n1. Diagnosed with malignancies;\n2. Diagnosed with psychiatric disorders;\n3. Diagnosed with cognitive impairment;\n4. Unable to operate smart wearable devices.","ALL","30 Years",{"count":86,"type":87},300,"ESTIMATED","INTERVENTIONAL",[90],"NA","The purpose of this study is to evaluate the control effect of smart wearable devices on key risk factors in the high-risk populations for stroke",[93,94,95,96,97,98,99],"Hypertension","Diabetes","Atrial Fibrillation","Dyslipidemia","Smoking","Physical Inactivity","Obesity and Overweight","2025-04-27",{"date":102,"type":103},"2025-04-30","ACTUAL",{"date":105,"type":103},"2025-04-20",{"date":107,"type":87},"2026-04-20",{"name":5,"class":6},1]